<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669836</url>
  </required_header>
  <id_info>
    <org_study_id>PCORI275</org_study_id>
    <nct_id>NCT02669836</nct_id>
  </id_info>
  <brief_title>Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia</brief_title>
  <official_title>Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins All Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arkansas Children's Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Healthcare of Atlanta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Colorado</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children’s Hospital of Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children’s Hospital of New York-Presbyterian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children’s Hospital of Phoenix</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital and Health System Foundation, Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gillette Children’s Hospital Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Levine Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ann &amp; Robert H Lurie Children's Hospital of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nicklaus Children's Hospital f/k/a Miami Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MUSC Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Primary Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children’s Hospital at OU Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Vermont Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UVA Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a posterior fossa decompression or a
      posterior fossa decompression with duraplasty results in better patient outcomes with fewer
      complications and improved quality of life in those who have Chiari malformation type I and
      syringomyelia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants with Chiari Malformation type I and syringomyelia will be randomized to either
      have a posterior fossa decompression done with or without duraplasty. The participant will
      then return to the neurosurgeon's office at the following time points which are consistent
      with standard of care practice: &lt; 6 weeks, 3-6 months, and 12 months. At these visits, the
      clinician will complete a physical exam and the participant will report on the prognosis of
      symptoms and complete two quality of life questionnaires. A brain and cervical spine MRI will
      be performed 12 months after the decompression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants with complications such as cerebrospinal fluid (CSF) leaks, pseudomeningoceles, infections, aseptic meningitis, hydrocephalus, and revisions.</measure>
    <time_frame>6 months from decompression</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The number of participants with complications such as cerebrospinal fluid (CSF) leaks, pseudomeningoceles, infections, aseptic meningitis, hydrocephalus, and revisions.</measure>
    <time_frame>12 months from decompression</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the change in size of syrinx before and after decompression.</measure>
    <time_frame>12 months</time_frame>
    <description>Syrinx size will be measured with radiographic imaging pre-operatively and 12 months post-operatively.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of quality of life using Children Health Index Pediatrics (CHIP) questionnaire.</measure>
    <time_frame>6 weeks from decompression</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of quality of life using Children Health Index Pediatrics (CHIP)questionnaire.</measure>
    <time_frame>6 months from decompression</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of quality of life using Children Health Index Pediatrics (CHIP)questionnaire.</measure>
    <time_frame>12 months from decompression</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of quality of life using Health Utilities 3 (HUI-3) questionnaire.</measure>
    <time_frame>6 weeks from decompression</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of quality of life using Health Utilities 3 (HUI-3) questionnaire.</measure>
    <time_frame>6 months from decompression</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of quality of life using Health Utilities 3 (HUI-3) questionnaire.</measure>
    <time_frame>12 months from decompression</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">216</enrollment>
  <condition>Arnold-Chiari Malformation, Type 1</condition>
  <condition>Chiari Malformation Type I</condition>
  <condition>Type I Arnold-Chiari Malformation</condition>
  <condition>Syringomyelia</condition>
  <arm_group>
    <arm_group_label>Posterior fossa decompression surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The bone is surgically removed from the suboccipital region of the skull and Cervical 1 lamina so the constricting epidural band can be resected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dural augmentation surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The bone is removed from the suboccipital region of the skull and Cervical 1 lamina so the constricting epidural band can be resected. Then, the dura is opened. Microsurgical dissection is performed and the dura is sewn closed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior fossa decompression</intervention_name>
    <description>Planned areas of bone removal from the suboccipital region of the skull and cervical l1 lamina. Then, the constricting epidural band at the level of the foramen magnum is resected.</description>
    <arm_group_label>Posterior fossa decompression surgery</arm_group_label>
    <other_name>Bone only posterior decompression</other_name>
    <other_name>Extradural posterior decompression</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dural Augmentation</intervention_name>
    <description>The dura is opened sharply, exposing the cerebellar tonsils, brainstem, and upper spinal cord. After microsurgical dissection, the dura is sewn closed with a dural graft.</description>
    <arm_group_label>Dural augmentation surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≤21 years old

          2. Chiari malformation type I ≥5 mm tonsillar ectopia

          3. Syrinx between 3 mm and 6 mm

          4. Chiari Severity Index (CSI) classification 1

          5. MRI of the brain and cervical and thoracic spine are required prior to surgery and
             must be available to be shared with the Data Coordinating Center

        Exclusion Criteria:

          1. CSI-2 or CSI-3 classification

          2. Syrinx &lt;3 mm and/or ≥6 mm

          3. Neuro-imaging demonstrating basilar invagination

          4. Clival canal angle &lt;120° (signs of severe craniovertebral junction disease)

          5. Chiari Malformation I + syringomyelia secondary to other pathology (e.g. a tumor)

          6. Unable to share pre-decompression MRI of the brain and cervical and thoracic spine

          7. Patients who do not wish to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David D Limbrick, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University-St. Louis Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David D Limbrick, MD, PhD</last_name>
    <phone>(314) 454-4454</phone>
    <email>LimbrickD1@wudosis.wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catharine Richard, BSN RN</last_name>
    <phone>(314) 454-3212</phone>
    <email>richardc@wudosis.wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Limbrick, M.D., PhD.</last_name>
      <phone>314-454-4454</phone>
      <email>limbrickD1@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Catharine Richard, BSN RN</last_name>
      <phone>314-454-3212</phone>
      <email>richardc@wudosis.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Limbrick, M.D., PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Di Lorenzo N, Cacciola F. Adult syringomielia. Classification, pathogenesis and therapeutic approaches. J Neurosurg Sci. 2005 Sep;49(3):65-72. Review.</citation>
    <PMID>16288188</PMID>
  </reference>
  <reference>
    <citation>Heiss JD, Patronas N, DeVroom HL, Shawker T, Ennis R, Kammerer W, Eidsath A, Talbot T, Morris J, Eskioglu E, Oldfield EH. Elucidating the pathophysiology of syringomyelia. J Neurosurg. 1999 Oct;91(4):553-62.</citation>
    <PMID>10507374</PMID>
  </reference>
  <reference>
    <citation>Small JA, Sheridan PH. Research priorities for syringomyelia: a National Institute of Neurological Disorders and Stroke workshop summary. Neurology. 1996 Feb;46(2):577-82.</citation>
    <PMID>8614541</PMID>
  </reference>
  <reference>
    <citation>Brickell KL, Anderson NE, Charleston AJ, Hope JK, Bok AP, Barber PA. Ethnic differences in syringomyelia in New Zealand. J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):989-91. Epub 2006 Mar 20.</citation>
    <PMID>16549414</PMID>
  </reference>
  <reference>
    <citation>Arnautovic A, Splavski B, Boop FA, Arnautovic KI. Pediatric and adult Chiari malformation Type I surgical series 1965-2013: a review of demographics, operative treatment, and outcomes. J Neurosurg Pediatr. 2015 Feb;15(2):161-77. doi: 10.3171/2014.10.PEDS14295. Epub 2014 Dec 5.</citation>
    <PMID>25479580</PMID>
  </reference>
  <reference>
    <citation>Fernández AA, Guerrero AI, Martínez MI, Vázquez ME, Fernández JB, Chesa i Octavio E, Labrado Jde L, Silva ME, de Araoz MF, García-Ramos R, Ribes MG, Gómez C, Valdivia JI, Valbuena RN, Ramón JR. Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment). BMC Musculoskelet Disord. 2009 Dec 17;10 Suppl 1:S1. doi: 10.1186/1471-2474-10-S1-S1. Review.</citation>
    <PMID>20018097</PMID>
  </reference>
  <reference>
    <citation>Hida K, Iwasaki Y, Koyanagi I, Abe H. Pediatric syringomyelia with chiari malformation: its clinical characteristics and surgical outcomes. Surg Neurol. 1999 Apr;51(4):383-90; discussion 390-1.</citation>
    <PMID>10199291</PMID>
  </reference>
  <reference>
    <citation>Mueller D, Oro' JJ. Prospective analysis of self-perceived quality of life before and after posterior fossa decompression in 112 patients with Chiari malformation with or without syringomyelia. Neurosurg Focus. 2005 Feb 15;18(2):ECP2.</citation>
    <PMID>15715455</PMID>
  </reference>
  <reference>
    <citation>Tisell M, Wallskog J, Linde M. Long-term outcome after surgery for Chiari I malformation. Acta Neurol Scand. 2009 Nov;120(5):295-9. doi: 10.1111/j.1600-0404.2009.01183.x. Epub 2009 Jun 11.</citation>
    <PMID>19519678</PMID>
  </reference>
  <reference>
    <citation>Greenberg JK, Yarbrough CK, Radmanesh A, Godzik J, Yu M, Jeffe DB, Smyth MD, Park TS, Piccirillo JF, Limbrick DD. The Chiari Severity Index: a preoperative grading system for Chiari malformation type 1. Neurosurgery. 2015 Mar;76(3):279-85; discussion 285. doi: 10.1227/NEU.0000000000000608.</citation>
    <PMID>25584956</PMID>
  </reference>
  <reference>
    <citation>Vakharia VN, Guilfoyle MR, Laing RJ. Prospective study of outcome of foramen magnum decompressions in patients with syrinx and non-syrinx associated Chiari malformations. Br J Neurosurg. 2012 Feb;26(1):7-11. doi: 10.3109/02688697.2011.578771. Epub 2011 May 18.</citation>
    <PMID>21591857</PMID>
  </reference>
  <reference>
    <citation>Munshi I, Frim D, Stine-Reyes R, Weir BK, Hekmatpanah J, Brown F. Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia. Neurosurgery. 2000 Jun;46(6):1384-9; discussion 1389-90.</citation>
    <PMID>10834643</PMID>
  </reference>
  <reference>
    <citation>Ventureyra EC, Aziz HA, Vassilyadi M. The role of cine flow MRI in children with Chiari I malformation. Childs Nerv Syst. 2003 Feb;19(2):109-13. Epub 2003 Jan 30.</citation>
    <PMID>12607030</PMID>
  </reference>
  <reference>
    <citation>Navarro R, Olavarria G, Seshadri R, Gonzales-Portillo G, McLone DG, Tomita T. Surgical results of posterior fossa decompression for patients with Chiari I malformation. Childs Nerv Syst. 2004 May;20(5):349-56. Epub 2004 Mar 12.</citation>
    <PMID>15022006</PMID>
  </reference>
  <reference>
    <citation>Limonadi FM, Selden NR. Dura-splitting decompression of the craniocervical junction: reduced operative time, hospital stay, and cost with equivalent early outcome. J Neurosurg. 2004 Nov;101(2 Suppl):184-8.</citation>
    <PMID>15835106</PMID>
  </reference>
  <reference>
    <citation>Yeh DD, Koch B, Crone KR. Intraoperative ultrasonography used to determine the extent of surgery necessary during posterior fossa decompression in children with Chiari malformation type I. J Neurosurg. 2006 Jul;105(1 Suppl):26-32.</citation>
    <PMID>16871867</PMID>
  </reference>
  <reference>
    <citation>Galarza M, Sood S, Ham S. Relevance of surgical strategies for the management of pediatric Chiari type I malformation. Childs Nerv Syst. 2007 Jun;23(6):691-6. Epub 2007 Jan 25.</citation>
    <PMID>17252266</PMID>
  </reference>
  <reference>
    <citation>Mutchnick IS, Janjua RM, Moeller K, Moriarty TM. Decompression of Chiari malformation with and without duraplasty: morbidity versus recurrence. J Neurosurg Pediatr. 2010 May;5(5):474-8. doi: 10.3171/2010.1.PEDS09218.</citation>
    <PMID>20433261</PMID>
  </reference>
  <reference>
    <citation>Litvack ZN, Lindsay RA, Selden NR. Dura splitting decompression for Chiari I malformation in pediatric patients: clinical outcomes, healthcare costs, and resource utilization. Neurosurgery. 2013 Jun;72(6):922-8; discussion 928-9. doi: 10.1227/NEU.0b013e31828ca1ed.</citation>
    <PMID>23426152</PMID>
  </reference>
  <reference>
    <citation>Lee A, Yarbrough CK, Greenberg JK, Barber J, Limbrick DD, Smyth MD. Comparison of posterior fossa decompression with or without duraplasty in children with Type I Chiari malformation. Childs Nerv Syst. 2014 Aug;30(8):1419-24. doi: 10.1007/s00381-014-2424-5. Epub 2014 Apr 29.</citation>
    <PMID>24777296</PMID>
  </reference>
  <reference>
    <citation>Rocque BG, George TM, Kestle J, Iskandar BJ. Treatment practices for Chiari malformation type I with syringomyelia: results of a survey of the American Society of Pediatric Neurosurgeons. J Neurosurg Pediatr. 2011 Nov;8(5):430-7. doi: 10.3171/2011.8.PEDS10427.</citation>
    <PMID>22044364</PMID>
  </reference>
  <reference>
    <citation>Batzdorf U. Primary spinal syringomyelia. Invited submission from the joint section meeting on disorders of the spine and peripheral nerves, March 2005. J Neurosurg Spine. 2005 Dec;3(6):429-35. Review.</citation>
    <PMID>16381204</PMID>
  </reference>
  <reference>
    <citation>Tubbs RS, Lyerly MJ, Loukas M, Shoja MM, Oakes WJ. The pediatric Chiari I malformation: a review. Childs Nerv Syst. 2007 Nov;23(11):1239-50. Epub 2007 Jul 18. Review.</citation>
    <PMID>17639419</PMID>
  </reference>
  <reference>
    <citation>Wellons JC &amp; Smyth MD (2013) Neurosurgical Face Off: Durotomy and Duraplasty Versus No Durotomy and Duraplasty. Annual Scientific Meeting of the American Association of Neurological Surgeons.</citation>
  </reference>
  <reference>
    <citation>Greenberg JK, Milner E, Yarbrough CK, Lipsey K, Piccirillo JF, Smyth MD, Park TS, Limbrick DD Jr. Outcome methods used in clinical studies of Chiari malformation Type I: a systematic review. J Neurosurg. 2015 Feb;122(2):262-72. doi: 10.3171/2014.9.JNS14406. Epub 2014 Nov 7. Review.</citation>
    <PMID>25380104</PMID>
  </reference>
  <reference>
    <citation>Durham SR, Fjeld-Olenec K. Comparison of posterior fossa decompression with and without duraplasty for the surgical treatment of Chiari malformation Type I in pediatric patients: a meta-analysis. J Neurosurg Pediatr. 2008 Jul;2(1):42-9. doi: 10.3171/PED/2008/2/7/042.</citation>
    <PMID>18590394</PMID>
  </reference>
  <reference>
    <citation>Ladner TR, Westrick AC, Wellons JC 3rd, Shannon CN. Health-related quality of life in pediatric Chiari Type I malformation: the Chiari Health Index for Pediatrics. J Neurosurg Pediatr. 2016 Jan;17(1):76-85. doi: 10.3171/2015.5.PEDS1513. Epub 2015 Oct 2.</citation>
    <PMID>26431245</PMID>
  </reference>
  <reference>
    <citation>Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol. 1992 Dec;45(12):1341-5.</citation>
    <PMID>1460470</PMID>
  </reference>
  <reference>
    <citation>Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis. 1985;38(1):27-36.</citation>
    <PMID>3972947</PMID>
  </reference>
  <reference>
    <citation>Carmines EG &amp; Zeller RA (1979) Reliability and Validity Assessment. Quatitative Applications in the Social Sciences. (Sage Publications, Newbury Park, CA).</citation>
  </reference>
  <reference>
    <citation>Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001 Jun;107(6):E99.</citation>
    <PMID>11389297</PMID>
  </reference>
  <reference>
    <citation>Yarbrough CK, Greenberg JK, Smyth MD, Leonard JR, Park TS, Limbrick DD Jr. External validation of the Chicago Chiari Outcome Scale. J Neurosurg Pediatr. 2014 Jun;13(6):679-84. doi: 10.3171/2014.3.PEDS13503. Epub 2014 Apr 11.</citation>
    <PMID>24724715</PMID>
  </reference>
  <reference>
    <citation>Weinstein JN, Lurie JD, Tosteson TD, Skinner JS, Hanscom B, Tosteson AN, Herkowitz H, Fischgrund J, Cammisa FP, Albert T, Deyo RA. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT) observational cohort. JAMA. 2006 Nov 22;296(20):2451-9.</citation>
    <PMID>17119141</PMID>
  </reference>
  <reference>
    <citation>Drake JM, Singhal A, Kulkarni AV, DeVeber G, Cochrane DD; Canadian Pediatric Neurosurgery Study Group. Consensus definitions of complications for accurate recording and comparisons of surgical outcomes in pediatric neurosurgery. J Neurosurg Pediatr. 2012 Aug;10(2):89-95. Epub 2012 Jun 22.</citation>
    <PMID>22725268</PMID>
  </reference>
  <reference>
    <citation>Donner A &amp; Klar N (2000) Design and Analysis of Cluster Randomization Trials in Health Research (Arnold; Oxford University Press, New York).</citation>
  </reference>
  <reference>
    <citation>Little RJA &amp; Rubin DB (2002) Statistical Analysis With Missing Data (Wiley, Hoboken, N.J.) Second Edition Ed.</citation>
  </reference>
  <reference>
    <citation>Buck SF (1960) A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J Roy Statist Soc 22:302-306.</citation>
  </reference>
  <reference>
    <citation>Godzik J, Kelly MP, Radmanesh A, Kim D, Holekamp TF, Smyth MD, Lenke LG, Shimony JS, Park TS, Leonard J, Limbrick DD. Relationship of syrinx size and tonsillar descent to spinal deformity in Chiari malformation Type I with associated syringomyelia. J Neurosurg Pediatr. 2014 Apr;13(4):368-74. doi: 10.3171/2014.1.PEDS13105. Epub 2014 Feb 14.</citation>
    <PMID>24527859</PMID>
  </reference>
  <reference>
    <citation>Greenberg JK, et al. (2014) Population-Based Analysis of Complications Associated with Chiari Malformation Type 1 Surgery in Children. AANS/CNS Joint Section on Pediatric Neurosurgery.</citation>
  </reference>
  <reference>
    <citation>Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1985 Jun;41(2):361-72.</citation>
    <PMID>4027319</PMID>
  </reference>
  <reference>
    <citation>Hankinson T, Tubbs RS, Wellons JC. Duraplasty or not? An evidence-based review of the pediatric Chiari I malformation. Childs Nerv Syst. 2011 Jan;27(1):35-40. doi: 10.1007/s00381-010-1295-7. Epub 2010 Oct 2. Review.</citation>
    <PMID>20890606</PMID>
  </reference>
  <reference>
    <citation>Marcus DS, Archie KA, Olsen TR, Ramaratnam M. The open-source neuroimaging research enterprise. J Digit Imaging. 2007 Nov;20 Suppl 1:130-8. Epub 2007 Aug 21.</citation>
    <PMID>17710494</PMID>
  </reference>
  <reference>
    <citation>Marcus DS, Olsen TR, Ramaratnam M, Buckner RL. The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data. Neuroinformatics. 2007 Spring;5(1):11-34.</citation>
    <PMID>17426351</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2016</study_first_submitted>
  <study_first_submitted_qc>January 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Syringomyelia</mesh_term>
    <mesh_term>Arnold-Chiari Malformation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

